Locally Recurrent Oral Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Locally Recurrent Oral Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-12-11Clinical Trial Update: Preoperative Tislelizumab -Cetuximab - Chemotherapy Followed by Salvage Surgery and Adjuvant Tislelizumab -Cetuximab for Resectable, Locally Recurrent Oral and Oropharyngeal Squamous Cell Carcinoma [Phase 2]
A Phase 2 clinical trial is planned to evaluate preoperative tislelizumab with cetuximab and chemotherapy followed by salvage surgery, plus …